ST. LOUIS, Jan. 16, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced today its intention to release its fourth quarter and full year earnings and 2015 earnings guidance on Monday, February 23, 2015 after the market closes and will hold its quarterly conference call to discuss fourth quarter and full year results and 2015 earnings guidance on Tuesday, February 24, 2015, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
The Company has scheduled an investor day meeting in St. Louis on February 25, 2015, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). At the meeting, senior leaders will discuss the Company's performance and future outlook and review how we create unique value for patients, payers and shareholders. The presentation will be broadcast via the Internet and can be accessed on the investor relations section of the Express Scripts web site at http://www.express-scripts.com.
A slide presentation will accompany the webcast. Following the meeting, both the slide presentation and the webcast will remain available on the investor relations section of the Express Scripts website for 30 days. RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the webcast site.
Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science(SM), our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
SOURCE Express Scripts Holding Company